Newsletters
Since I’ve noticed that many newsletters end up in the recipient’s SPAM folder, I’ve created this page as a precaution where all newsletters will be published.
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Newsletter 31/2026 August 2, 2026
- Phase 2 Trial for Xaluritamig in Patients With mCRPC and Suboptimal Response to Pluvicto July 31, 2026
- Phase 1 Trial for ASP388B July 31, 2026
- UPDATE: FX-111 Entered Clinical Trials Phase July 31, 2026
Newsletter 22/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! From the hottest Italian May I can remember, here’s what’s happening in cancer research and clinical trials. Stay strong and fight on! As usual, we also have a podcast if you prefer to listen to the newsletter, you can find […]
Newsletter 21/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! This week we have a solid set of clinical trials and retrospective studies. We are making progress day by day. Stay strong and fight on! As usual, we also have a podcast if you prefer to listen to the […]
Newsletter 20/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hello fellow warriors! As you can probably tell, every now and then I blow off steam by generating images with AI! This week we have quite a few updates on the clinical trial front, as well as some interesting insights from preclinical […]